Affiliations
AffiliationsItem in Clipboard
Mobile Health in Oncology: A Patient Survey About App-Assisted Cancer CareKerstin Anne Kessel et al. JMIR Mhealth Uhealth. 2017.
doi: 10.2196/mhealth.7689. Authors Kerstin Anne Kessel 1 2 , Marco Me Vogel 1 2 , Carmen Kessel 1 3 , Henning Bier 4 , Tilo Biedermann 5 , Helmut Friess 6 , Peter Herschbach 7 , Rüdiger von Eisenhart-Rothe 8 , Bernhard Meyer 9 , Marion Kiechle 10 , Ulrich Keller 11 , Christian Peschel 11 , Roland M Schmid 12 , Stephanie E Combs 1 2 3 AffiliationsItem in Clipboard
AbstractBackground: In the last decade, the health care sector has been enriched by numerous innovations such as apps and connected devices that assist users in weight reduction and diabetes management. However, only a few native apps in the oncological context exist, which support patients during treatment and aftercare.
Objective: The objective of this study was to analyze patients' acceptance regarding app use and to investigate the functions of an oncological app that are most required, and the primary reasons for patients to refuse app-assisted cancer care.
Methods: We designed and conducted a survey with 23 questions, inquiring patients about their technical knowledge and equipment, as well as the possible advantages and disadvantages, data transfer, and general functionality of an app.
Results: A total of 375 patients participated; the participation rate was 60.7% (375/618). Gender distribution was about 3:4 (female:male) with a median age of 59 years (range 18-92 years). Whereas 69.6% (261/375) of patients used mobile devices, 16.3% (61/375) did not own one, and 9.1% (34/375) only used a personal computer (PC). About half of the patients rated their usability skills as very good and good (18.9% 71/375; 35.2% 132/375), 23.5% (88/375) described their skills as intermediate, and 14.4% (54/375) as bad. Of all patients, 182 (48.5%, 182/375) were willing to send data to their treating clinic via an app, that is, to a server (61.0% 111/182) or as email (33.5%, 61/182). About two-thirds (68.7%, 125/182) believed that additional and regularly sent data would be an ideal complement to the standard follow-up procedure. Additionally, 86.8% (158/182) wished to be contacted by a physician when entered data showed irregularities. Because of lack of skills (34.4%, 56/163), concerns about the use of data (35.0%, 57/163), lack of capable devices (25.8%, 42/163), and the wish for personal contact with the treating physician (47.2%, 77/163), a total of 163 (43.5%, 163/375) patients refused to use an app. Pearson correlation showed a significant but mild relationship between age and app use (P=.03, r=-.12), favoring younger age; male gender correlated as well (P=.04; r=-.11).
Conclusions: The results show that the introduction of mobile apps needs to follow different strategies depending on the patients' attitude. Age and gender seem to be the strongest predictive factors. For oncology patients, our survey showed that about half of the patients were willing to send data via an app supporting their treatment. In the future, clinical data such as quality of life and treatment satisfaction recorded by mobile health (mHealth) devices could be used to evaluate and improve therapy workflow. Furthermore, apps could support classical visits, document adverse effects, and remind patients of treatment dates or drug intake.
Keywords: clinical oncology; eHealth; mHealth; mobile apps; surveys and questionnaires.
©Kerstin Anne Kessel, Marco ME Vogel, Carmen Kessel, Henning Bier, Tilo Biedermann, Helmut Friess, Peter Herschbach, Rüdiger von Eisenhart-Rothe, Bernhard Meyer, Marion Kiechle, Ulrich Keller, Christian Peschel, Roland M Schmid, Stephanie E Combs. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 14.06.2017.
Conflict of interest statementConflicts of Interest: None declared.
FiguresFigure 1
Q9.1: Which data are you…
Figure 1
Q9.1: Which data are you willing to transfer? (n=182).
Figure 1Q9.1: Which data are you willing to transfer? (n=182).
Figure 2
Q9.2: Why would you not…
Figure 2
Q9.2: Why would you not send data via an app to your treating…
Figure 2Q9.2: Why would you not send data via an app to your treating clinic? (n=163).
Figure 3
Q11: What would be important…
Figure 3
Q11: What would be important to you when considering using an app? (n=182).
Figure 3Q11: What would be important to you when considering using an app? (n=182).
Figure 4
Q21: Figure listing desired additional…
Figure 4
Q21: Figure listing desired additional functions (n=182).
Figure 4Q21: Figure listing desired additional functions (n=182).
Similar articlesKessel KA, Vogel MME, Schmidt-Graf F, Combs SE. Kessel KA, et al. J Med Internet Res. 2016 Nov 24;18(11):e312. doi: 10.2196/jmir.6399. J Med Internet Res. 2016. PMID: 27884810 Free PMC article.
El Shafie RA, Weber D, Bougatf N, Sprave T, Oetzel D, Huber PE, Debus J, Nicolay NH. El Shafie RA, et al. JMIR Mhealth Uhealth. 2018 Aug 30;6(8):e10916. doi: 10.2196/10916. JMIR Mhealth Uhealth. 2018. PMID: 30166275 Free PMC article.
Kessel KA, Vogel MM, Alles A, Dobiasch S, Fischer H, Combs SE. Kessel KA, et al. JMIR Mhealth Uhealth. 2018 Feb 20;6(2):e45. doi: 10.2196/mhealth.9486. JMIR Mhealth Uhealth. 2018. PMID: 29463489 Free PMC article.
Rincon E, Monteiro-Guerra F, Rivera-Romero O, Dorronzoro-Zubiete E, Sanchez-Bocanegra CL, Gabarron E. Rincon E, et al. JMIR Mhealth Uhealth. 2017 Dec 4;5(12):e187. doi: 10.2196/mhealth.8741. JMIR Mhealth Uhealth. 2017. PMID: 29203459 Free PMC article. Review.
Majeed-Ariss R, Baildam E, Campbell M, Chieng A, Fallon D, Hall A, McDonagh JE, Stones SR, Thomson W, Swallow V. Majeed-Ariss R, et al. J Med Internet Res. 2015 Dec 23;17(12):e287. doi: 10.2196/jmir.5043. J Med Internet Res. 2015. PMID: 26701961 Free PMC article. Review.
Sprave T, Pfaffenlehner M, Stoian R, Christofi E, Rühle A, Zöller D, Fabian A, Fahrner H, Binder H, Schäfer H, Gkika E, Grosu AL, Heinemann F, Nicolay NH. Sprave T, et al. J Med Internet Res. 2023 Oct 19;25:e46189. doi: 10.2196/46189. J Med Internet Res. 2023. PMID: 37856185 Free PMC article. Clinical Trial.
Hauth F, Bizu V, App R, Lautenbacher H, Tenev A, Bitzer M, Malek NP, Zips D, Gani C. Hauth F, et al. JMIR Mhealth Uhealth. 2019 Jul 24;7(7):e12345. doi: 10.2196/12345. JMIR Mhealth Uhealth. 2019. PMID: 31342906 Free PMC article.
Tarricone R, Cucciniello M, Armeni P, Petracca F, Desouza KC, Hall LK, Keefe D. Tarricone R, et al. JMIR Mhealth Uhealth. 2019 Sep 6;7(9):e13584. doi: 10.2196/13584. JMIR Mhealth Uhealth. 2019. PMID: 31493318 Free PMC article.
Brusniak K, Feisst M, Sebesteny L, Hartkopf A, Graf J, Engler T, Schneeweiss A, Wallwiener M, Deutsch TM. Brusniak K, et al. JMIR Cancer. 2021 Oct 12;7(4):e25776. doi: 10.2196/25776. JMIR Cancer. 2021. PMID: 34636732 Free PMC article.
Rezaee R, Asadi S, Yazdani A, Rezvani A, Kazeroon AM. Rezaee R, et al. Health Sci Rep. 2022 Jun 26;5(4):e708. doi: 10.1002/hsr2.708. eCollection 2022 Jul. Health Sci Rep. 2022. PMID: 35782301 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3